Jesse Chen

Co-Founder & CTO

Triana Biomedicines

Helai Mohammad

VP, Head of Biology

Proteovant Therapeutics

Gwenn Hansen

Chief Scientific Officer

Nurix Therapeutics

Gisele Nishiguchi

Lead Scientist, Group Leader

St. Jude Children's Research Hospital

Eric Fischer

Associate Professor, Principal Investigator

Dana Farber Cancer Institute

Aparajita Chourasia

VP, Biology

Biotheryx

Amit Choudhary

Assistant Professor, Scientific Founder

Harvard Medical School/Photys Therapeutics

Adam Gilbert

Executive Director, External Accelerator

Pfizer

Sanja Hukovic

Head of Model Risk Management

London Stock Exchange Group

Allan Hackshaw

Professor of Epidemiology & Medical Statistics

University College London

Allan Hackshaw is Professor of Epidemiology & Medical Statistics at University College London, and Director of the Cancer Research UK & UCL Cancer Trials Centre. He has over 30 years’ experience in the design, conduct, analysis and interpretation of cohort/case-control studies, large real-world data studies, phase I-III clinical trials, and systematic reviews; in several areas including cancer, and tobacco and health. His particular focus has been on adult (mainly cancer) and prenatal screening, as a key investigator on large scale studies, some of which have evaluated new screening tests and policies that later became routine practice. He is a member of the UK National Screening Committee Adult Reference Group, and co-editor of the Journal of Medical Screening. He has published more than 200 journal articles and book chapters, and sole or first author of four textbooks.